These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34639214)

  • 1. LEF1 Enhances the Progression of Colonic Adenocarcinoma via Remodeling the Cell Motility Associated Structures.
    Xiao L; Zhang C; Li X; Jia C; Chen L; Yuan Y; Gao Q; Lu Z; Feng Y; Zhao R; Zhao X; Cheng S; Shu Z; Xu J; Duan W; Nie G; Hou Y
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of N-terminal Annexin A2 phosphorylation sites and miR-206 in colonic adenocarcinoma.
    Xiao L; Jin H; Duan W; Hou Y
    Life Sci; 2020 Jul; 253():117740. PubMed ID: 32376265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancer.
    Wu L; Zhao JC; Kim J; Jin HJ; Wang CY; Yu J
    Cancer Res; 2013 Oct; 73(19):6068-79. PubMed ID: 23913826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of lymphoid enhancer factor 1 inhibits colon cancer progression in vitro and in vivo.
    Wang WJ; Yao Y; Jiang LL; Hu TH; Ma JQ; Liao ZJ; Yao JT; Li DF; Wang SH; Nan KJ
    PLoS One; 2013; 8(10):e76596. PubMed ID: 24098538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of LEF1/TCFs family members in colonic carcinogenesis.
    Han W; He L; Cao B; Zhao X; Zhang K; Li Y; Beck P; Zhou Z; Tian Y; Cheng S; Wang H
    Mol Carcinog; 2017 Nov; 56(11):2372-2381. PubMed ID: 27433921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of microRNA-708 on Epithelial-Mesenchymal Transition, Cell Proliferation and Apoptosis in Melanoma Cells by Targeting LEF1 through the Wnt Signaling Pathway.
    Song XF; Wang QH; Huo R
    Pathol Oncol Res; 2019 Jan; 25(1):377-389. PubMed ID: 29138985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of association of OCT4 with LEF1 expression in esophageal squamous cell carcinoma and their impact on epithelial-mesenchymal transition, invasion, and migration.
    Zhao Y; Li C; Huang L; Niu S; Lu Q; Gong D; Huang S; Yuan Y; Chen H
    Cancer Med; 2018 Aug; 7(8):3977-3987. PubMed ID: 29974668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ANXA2 remodels the microstructures of caco2 cells.
    Xing R; He H; He Y; Feng Y; Zhang C; Wu H; Sun M; Yu X; Liu Y; Song X; Wang X; Chen Y; Hou Y
    Cell Mol Biol (Noisy-le-grand); 2013 Feb; 59 Suppl():OL1848-54. PubMed ID: 23522334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of DNA-dependent protein kinase catalytic subunit as a novel interaction partner of lymphocyte enhancer factor 1.
    Shimomura A; Takasaki A; Nomura R; Hayashi N; Senda T
    Med Mol Morphol; 2013 Mar; 46(1):14-9. PubMed ID: 23325550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
    Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X
    Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of LEF1 by MYC activates the WNT pathway and maintains cell proliferation.
    Hao YH; Lafita-Navarro MC; Zacharias L; Borenstein-Auerbach N; Kim M; Barnes S; Kim J; Shay J; DeBerardinis RJ; Conacci-Sorrell M
    Cell Commun Signal; 2019 Oct; 17(1):129. PubMed ID: 31623618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear LEF1/TCF4 correlate with poor prognosis but not with nuclear β-catenin in cerebral metastasis of lung adenocarcinomas.
    Bleckmann A; Siam L; Klemm F; Rietkötter E; Wegner C; Kramer F; Beissbarth T; Binder C; Stadelmann C; Pukrop T
    Clin Exp Metastasis; 2013 Apr; 30(4):471-82. PubMed ID: 23224985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF2BP1 promotes mesenchymal cell properties and migration of tumor-derived cells by enhancing the expression of LEF1 and SNAI2 (SLUG).
    Zirkel A; Lederer M; Stöhr N; Pazaitis N; Hüttelmaier S
    Nucleic Acids Res; 2013 Jul; 41(13):6618-36. PubMed ID: 23677615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-381 inhibits metastasis and epithelial-mesenchymal transition of glioblastoma cells through targeting LEF1.
    Min RQ; Ma Q
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6825-6833. PubMed ID: 32633375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNAIL1 employs β-Catenin-LEF1 complexes to control colorectal cancer cell invasion and proliferation.
    Freihen V; Rönsch K; Mastroianni J; Frey P; Rose K; Boerries M; Zeiser R; Busch H; Hecht A
    Int J Cancer; 2020 Apr; 146(8):2229-2242. PubMed ID: 31463973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LEF1 Targeting EMT in Prostate Cancer Invasion Is Regulated by miR-34a.
    Liang J; Li Y; Daniels G; Sfanos K; De Marzo A; Wei J; Li X; Chen W; Wang J; Zhong X; Melamed J; Zhao J; Lee P
    Mol Cancer Res; 2015 Apr; 13(4):681-8. PubMed ID: 25587085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-26b represses colon cancer cell proliferation by inhibiting lymphoid enhancer factor 1 expression.
    Zhang Z; Kim K; Li X; Moreno M; Sharp T; Goodheart MJ; Safe S; Dupuy AJ; Amendt BA
    Mol Cancer Ther; 2014 Jul; 13(7):1942-51. PubMed ID: 24785257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA LEF1-AS1 silencing suppresses the initiation and development of prostate cancer by acting as a molecular sponge of miR-330-5p via LEF1 repression.
    Liu DC; Song LL; Liang Q; Hao L; Zhang ZG; Han CH
    J Cell Physiol; 2019 Aug; 234(8):12727-12744. PubMed ID: 30613973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LEF1 reduces tumor progression and induces myodifferentiation in a subset of rhabdomyosarcoma.
    Dräger J; Simon-Keller K; Pukrop T; Klemm F; Wilting J; Sticht C; Dittmann K; Schulz M; Leuschner I; Marx A; Hahn H
    Oncotarget; 2017 Jan; 8(2):3259-3273. PubMed ID: 27965462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LEF1-AS1, long non-coding RNA, inhibits proliferation in myeloid malignancy.
    Congrains-Castillo A; Niemann FS; Santos Duarte AS; Olalla-Saad ST
    J Cell Mol Med; 2019 Apr; 23(4):3021-3025. PubMed ID: 30770626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.